Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Impacts of aquatic walking on arterial stiffness, exercise tolerance, and physical function in patients with peripheral artery disease: a randomized clinical trial [with consumer summary]
Park S-Y, Kwak Y-S, Pekas EJ
Journal of Applied Physiology 2019 Oct;127(4):940-949
clinical trial
6/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

Peripheral artery disease (PAD) is an atherosclerotic disease that is associated with attenuated vascular function, cardiorespiratory capacity, physical function, and muscular strength. It is essential to combat these negative effects on health by incorporating lifestyle interventions to slow disease progression, such as exercise. We sought to examine the effects of aquatic walking exercise on cardiovascular function, cardiorespiratory capacity (maximal volume of oxygen consumption (VO2max)), exercise tolerance (6-min walking distance (6MWD)), physical function, muscular strength, and body composition in patients with PAD. Patients with PAD (n = 72) were recruited and randomly assigned to a 12-wk aquatic walking training group (AQ, n = 35) or a control group (CON, n = 37). The AQ group performed walking and leg exercises in waist-to-chest-deep water. Leg arterial stiffness (femoral-to-ankle pulse wave velocity (legPWV)), heart rate (HR), blood pressure (BP), ankle-to-brachial index (ABI), VO2max, 6MWD, physical function, muscular strength, body composition, resting metabolic rate (RMR), and flexibility were measured before and after 12 wk. There were significant group x time interactions (p < 0.05) after 12 wk for legPWV and HR, which significantly decreased (p < 0.05) in AQ, and VO2max, 6MWD, physical function, and muscular strength, which significantly increased (p < 0.05) in AQ, compared with no changes in CON. There were no significant differences (p > 0.05) for BP, ABI, RMR, or flexibility after 12 wk. Interestingly, there was relatively high adherence (84%) to the aquatic walking exercise program in this population. These results suggest that aquatic walking exercise is an effective therapy to reduce arterial stiffness and resting HR and improve cardiorespiratory capacity, exercise tolerance, physical function, and muscular strength in patients with PAD.

Full text (sometimes free) may be available at these link(s):      help